Applied DNA Sciences Inc. (APDN) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Applied DNA Sciences Inc. (APDN)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.18

-0.01 (-6.93%)

At close: Jan 14, 2025, 3:59 PM

0.19

4.17%

Pre-market Jan 15, 2025, 06:35 AM EST

undefined% (undefined)

Bid	0.19
Market Cap	9.54M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.78
PE Ratio (ttm)	-0.1
Forward PE	n/a
Analyst	Buy

Ask	0.2
Volume	1,842,647
Avg. Volume (20D)	6,278,836
Open	0.19
Previous Close	0.19
Day's Range	0.18 - 0.20
52-Week Range	0.12 - 14.40
Beta	undefined

About APDN

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection ...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Jul 15, 2003

Employees 52

Stock Exchange NASDAQ

Ticker Symbol APDN

Website https://www.adnas.com

Analyst Forecast

According to 1 analyst ratings, the average rating for APDN stock is "Buy." The 12-month stock price forecast is $1.5, which is an increase of 722.37% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Applied DNA Sciences Inc. is scheduled to release its earnings on Feb 13, 2025, after market closes.
Analysts project revenue of $1.18M, reflecting a 32.41% YoY growth and earnings per share of -0.33, making a 266.67% increase YoY.

Why Price Moved

4 weeks ago · Source

+24.46%

Applied DNA Sciences shares are trading lower afte... Unlock content with Pro Subscription

2 months ago · Source

-40.56%

Applied DNA shares are trading lower after the company announced the pricing of a registered direct offering of 20,312,500 shares at $0.32 per share. The company also announced a concurrent private placement.

News

4 weeks ago · zacks.com

Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates

Applied DNA Sciences (APDN) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $5.20 per share a year ago.